tiprankstipranks
Trending News
More News >
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market

Iradimed (IRMD) Ratios

Compare
155 Followers

Iradimed Ratios

IRMD's free cash flow for Q1 2025 was $0.76. For the 2025 fiscal year, IRMD's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.87 4.65 9.14 11.18 12.96
Quick Ratio
7.62 3.87 8.51 10.54 12.16
Cash Ratio
5.94 3.05 6.78 9.09 10.18
Solvency Ratio
1.73 0.87 1.14 0.93 0.20
Operating Cash Flow Ratio
3.07 0.82 1.17 1.65 1.18
Short-Term Operating Cash Flow Coverage
439.60 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 63.46M$ 55.27M$ 66.35M$ 65.54M$ 54.05M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.02 0.03 0.03 0.04
Debt-to-Equity Ratio
<0.01 0.03 0.03 0.03 0.04
Debt-to-Capital Ratio
<0.01 0.03 0.03 0.03 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.13 1.29 1.16 1.15 1.16
Debt Service Coverage Ratio
296.76 0.00 22.25 0.00 0.00
Interest Coverage Ratio
0.00 0.00 26.86 0.00 0.00
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.16 0.22 0.20 0.22
Net Debt to EBITDA
-2.21 -2.29 -3.42 -5.30 -81.26
Profitability Margins
Gross Profit Margin
76.91%76.50%77.45%76.65%74.33%
EBIT Margin
24.49%30.56%29.32%23.52%-2.38%
EBITDA Margin
30.29%31.73%30.58%26.84%1.84%
Operating Profit Margin
30.13%30.56%29.32%23.48%-2.38%
Pretax Profit Margin
33.23%33.16%30.36%23.52%-1.94%
Net Profit Margin
26.33%26.22%24.07%22.30%4.32%
Continuous Operations Profit Margin
26.33%26.22%24.07%22.30%4.32%
Net Income Per EBT
79.21%79.09%79.28%94.81%-221.92%
EBT Per EBIT
110.29%108.50%103.54%100.19%81.59%
Return on Assets (ROA)
19.45%18.66%15.00%11.25%1.93%
Return on Equity (ROE)
23.28%24.07%17.41%12.92%2.23%
Return on Capital Employed (ROCE)
24.29%26.42%20.31%12.91%-1.14%
Return on Invested Capital (ROIC)
19.22%20.78%16.04%12.19%2.53%
Return on Tangible Assets
20.09%19.18%15.37%11.41%1.95%
Earnings Yield
2.56%2.87%3.61%1.63%0.50%
Efficiency Ratios
Receivables Turnover
5.91 5.36 4.02 8.14 6.93
Payables Turnover
6.70 8.29 6.68 12.47 12.39
Inventory Turnover
1.64 1.20 2.24 2.27 2.07
Fixed Asset Turnover
3.68 5.79 22.21 9.19 6.56
Asset Turnover
0.74 0.71 0.62 0.50 0.45
Working Capital Turnover Ratio
1.13 1.01 0.77 0.65 0.57
Cash Conversion Cycle
229.29 327.85 199.30 176.30 199.53
Days of Sales Outstanding
61.71 68.06 90.90 44.84 52.65
Days of Inventory Outstanding
222.07 303.80 163.03 160.73 176.34
Days of Payables Outstanding
54.49 44.00 54.63 29.26 29.45
Operating Cycle
283.78 371.85 253.93 205.56 228.98
Cash Flow Ratios
Operating Cash Flow Per Share
2.05 1.07 0.80 0.91 0.48
Free Cash Flow Per Share
1.10 0.43 0.65 0.85 0.43
CapEx Per Share
0.95 0.64 0.15 0.06 0.05
Free Cash Flow to Operating Cash Flow
0.54 0.41 0.81 0.93 0.89
Dividend Paid and CapEx Coverage Ratio
1.31 0.63 0.70 15.18 9.14
Capital Expenditure Coverage Ratio
2.16 1.68 5.36 15.18 9.14
Operating Cash Flow Coverage Ratio
439.60 6.59 4.55 4.54 2.14
Operating Cash Flow to Sales Ratio
0.35 0.21 0.19 0.27 0.18
Free Cash Flow Yield
1.81%0.91%2.30%1.84%1.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
39.07 34.80 27.70 61.18 201.91
Price-to-Sales (P/S) Ratio
10.29 9.13 6.67 13.64 8.72
Price-to-Book (P/B) Ratio
8.58 8.38 4.82 7.90 4.50
Price-to-Free Cash Flow (P/FCF) Ratio
55.23 109.62 43.51 54.25 53.35
Price-to-Operating Cash Flow Ratio
29.69 44.43 35.39 50.68 47.51
Price-to-Earnings Growth (PEG) Ratio
14.94 1.04 0.81 0.10 -2.32
Price-to-Fair Value
8.58 8.38 4.82 7.90 4.50
Enterprise Value Multiple
31.75 26.47 18.39 45.53 393.08
Enterprise Value
722.81M 550.54M 299.65M 511.00M 229.06M
EV to EBITDA
31.75 26.47 18.39 45.53 393.08
EV to Sales
9.62 8.40 5.62 12.22 7.22
EV to Free Cash Flow
51.64 100.87 36.69 48.59 44.21
EV to Operating Cash Flow
27.76 40.89 29.84 45.39 39.37
Tangible Book Value Per Share
6.83 5.47 5.70 5.76 4.98
Shareholders’ Equity Per Share
7.08 5.67 5.86 5.85 5.06
Tax and Other Ratios
Effective Tax Rate
0.21 0.21 0.21 0.05 3.22
Revenue Per Share
5.91 5.20 4.24 3.39 2.62
Net Income Per Share
1.56 1.36 1.02 0.76 0.11
Tax Burden
0.79 0.79 0.79 0.95 -2.22
Interest Burden
1.36 1.08 1.04 1.00 0.82
Research & Development to Revenue
0.04 0.04 0.04 0.05 0.06
SG&A to Revenue
0.22 0.23 0.20 0.23 0.39
Stock-Based Compensation to Revenue
0.04 0.03 0.03 0.03 0.12
Income Quality
1.32 0.78 0.78 1.21 4.25
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis